860 High-Risk Pharma Units Face Regulatory Action Under Quality Drive: DCGI Written By sheeba farhat31 July 2026 10:52 PM ISTNew Delhi: India has taken enforcement action against about 90% of inspected pharmaceutical facilities identified as high-risk under a nationwide...
CDSCO Cancels Import Registration for IVATHERM Cosmetics Held by Mylan Pharma Written By Susmita Roy29 July 2026 10:57 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has cancelled the cosmetic import registration certificate held by Mylan...
CDSCO Approves AstraZeneca's Enhertu for Neoadjuvant HER2-Positive Breast Cancer Written By Parthika Patel28 July 2026 10:16 PM ISTNew Delhi: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation (CDSCO), Directorate General...
CDSCO Cancels Registration of Seven Ethics Committees for Major Compliance Failures Written By Susmita Roy27 July 2026 2:30 PM ISTNew Delhi: In one of the strongest regulatory actions taken to safeguard the integrity of clinical research in India, the Central Drugs Standard...
CDSCO State Drug Alert: 132 Drug Batches Including Telmisartan, Azithromycin Fail Quality Tests Written By Susmita Roy24 July 2026 10:50 PM ISTNew Delhi: In another major drug quality surveillance exercise, 132 batches of drugs, cosmetics and Ayurvedic products have been declared Not of...
CDSCO Probes Two Suspected Spurious Antibiotic Batches of Cefixime, Amoxycillin-Clavulanate Written By Susmita Roy23 July 2026 10:37 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued an alert regarding Cefixime Dispersible Tablets IP and Amoxycillin and...
CDSCO Flags 27 Drug Batches Including Paracetamol, Ibuprofen, Levetiracetam as Not of Standard Quality Written By Susmita Roy22 July 2026 10:23 PM ISTNew Delhi: In a fresh drug quality alert highlighting continued regulatory surveillance, 27 batches of drugs and one medical device have been declared...
Emcure's Poviztra Cleared for Fatty Liver Treatment Following CDSCO Nod to Wegovy Written By sheeba farhat21 July 2026 9:35 PM ISTNew Delhi: Emcure Pharmaceuticals Ltd on Monday said its co-marketed brand of the innovator semaglutide, Poviztra, will now be available for the...
CDSCO Approves Novo Nordisk's Wegovy for Fatty Liver Disease in India Written By sheeba farhat19 July 2026 11:15 AM ISTNew Delhi: Novo Nordisk India on Friday said it has received approval from the Central Drugs Standard Control Organisation for indication of its...
CDSCO Approves AstraZeneca's Fasenra for Hypereosinophilic Syndrome in India Written By Parthika Patel18 July 2026 5:05 PM ISTBengaluru: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organization (CDSCO), Directorate General...
Govt Committee Proposes Central Database to Identify and Ban Unapproved Drugs, FDCs from Market Written By Susmita Roy9 July 2026 8:45 PM ISTNew Delhi: The Drugs Consultative Committee (DCC) has proposed a comprehensive regulatory mechanism to permanently address the long-standing issue of...
CDSCO Asks Pharma Firms to Update Vancomycin Labels with DRESS Syndrome ADR Written By Susmita Roy8 July 2026 8:03 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has directed all State and Union Territory licensing authorities to instruct...
